Media-OutReach Newswire AIM Vaccine has obtained clinical approval for two heavyweight products, creating new growth points for performance
Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Hà Nội proposes financial support, preferential loans for electric vehicle transition ahead of ban 3.
ICONSIAM’s ‘THAICONIC SONGKRAN CELEBRATION 2025’ to Captivate Visitors with Thailand’s Most Spectacular Water Festival 3.